Since KMT2D mutations in patients with leukemia co‐occur with TP53 and NF1 mutations, we tested the effects of Kmt2d deficiency in mice in the context of Trp53 and Nf1 deletion (Figure S1B and Table S1, Supporting Information). This evidence concerns the gene NF1 and leukemia.